WASHINGTON — The Trump administration will announce on Tuesday that it has signed a $354 million four-year contract with a new company in Richmond, Va., to manufacture generic medicines and pharmaceutical ingredients that are needed to treat Covid-19 but are now made overseas, mostly in India and China. The contract, awarded to Phlow Corp. by the Biomedical Advanced Research and Development Authority, meshes President Trump’s “America First”…
More Stories
LGBTQ-inclusive books are hard to find. So these groups started sending them to schools.
At least six arrested as ‘Stop the Steal’ protesters and counter-protesters clash in Washington, DC
Two LA County sheriff’s deputies involved in the fatal shooting of Andres Guardado relieved of duties following unrelated investigation